ARUP's Laboratory Test Directory
| 0080080: Carcinoembryonic Antigen |
| Test Mnemonic: CEA | |
|
#ExistMethodology>
Methodology: Eletrochemiluminescent Immunoassay
*ExistMethodology> #ExistPerformed> Performed: Sun-Sat *ExistPerformed> #ExistReported> Reported: Within 24 hours *ExistReported> |
| Specimen Required: | |
|
#ExistCollect>
Collect: One 4 mL SST.
*ExistCollect> #ExistTransport> Transport: 1 mL serum at 2-8°C. (Min: 0.6 mL) Submit specimen in an ARUP Standard Transport Tube. *ExistTransport> #ExistPedCollectTransport> Pediatric Collection/Transport: 0.4 mL serum at 2-8°C. *ExistPedCollectTransport> #ExistRemarks> Remarks: Allow specimen to clot completely at room temperature. Separate serum from cells ASAP. Frozen specimens are also acceptable. *ExistRemarks> #ExistConditions> Unacceptable Conditions: Plasma *ExistConditions> #ExistStability> Stability: After separation from cells: Ambient: 8 hours; Refrigerated: 1 week; Frozen: 6 month *ExistStability> |
|
| Reference Interval: |
| #ExistRefRange> 0.0-3.0 ng/mL *ExistRefRange> |
| Interpretive Data: | |
|
#ExistInterpData>
The Roche Modular E170 CEA electrochemiluminescent immunoassay is used. Results obtained with different assay methods or kits cannot be used interchangeably. Measurement of CEA has been shown to be clinically relevant in the management of patients with colorectal, breast, lung, prostatic, pancreatic, and ovarian carcinomas. Smokers may have slightly elevated levels of CEA. The CEA assay value, regardless of level, should not be interpreted as evidence for the presence or absence of malignant disease and is not recommended for use as a screening procedure to detect the presence of cancer in the general population.
*ExistInterpData> |
| CPT Code(s): | |
| 82378 |